Ashishchandra Rao

Not All Moratoriums Operate The Same Way: A Cautionary Tale

No Love Lost Between SEBI And BSE: A Notional Demand

Marketing Code For Pharmaceutical Companies Gets Tougher: A Comparison Of The 2024 And 2014 Codes

New Regulations In Play At The Brink Of 2024: Enhancing Controls For Regulatory Entities And Alternative Investment Funds

Delhi High Court Judgment In Bharat Serums – A Relief To Drug Manufacturers

Regulating Medical Practice: The Key Reforms Introduced By The Registered Medical Practitioner (Professional Conduct) Regulations, 2023

Resolving Disputes With Discretion: Analyzing Confidentiality In Arbitration Proceedings

Whale Of A Tale: Tracing The Centre's Recent Ban On 14 FDCs Approved Prior To 1988

Regulatory Blindspot and Contradictions: Sale, Manufacturing and Price Regulation of India's Medical Devices market

The Conundrum Of Procedure: Extension Of The Mandate Of The Arbitral Tribunal. Who Has Jurisdiction?